ARCHIVES

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

ACO Leaders Meet With Key White House, Hill Aides

March 29, 1985

FASEB: Focus on Research Funding, Not PR

June 14, 2013

In Brief: Mihich, Kennedy, Aust New Presidents; Loeb, Coltman, Cady Presidents Elect; Carbone Honored

May 29, 1987

How Cancer Control Grants, Contracts Distributed By States

October 13, 1978

In Brief: Conference Agrees On $1.664 Billion NCI Budget; NIH Alums Bishop, Varmus Of CSF Win Nobel

October 13, 1989

In Brief: HHS Finds Fisher, Wickerham, Redmond Did Not Commit Scientific Misconduct

March 7, 1997